Patents
US 11813279 B2: Compositions for cancer therapy and methods
- Granted
- 2023-11-14
- Filed
- 2019-08-09 application 16537442
- Type
- Utility · 29 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
One aspect of this disclosure is directed to a method for treating a cancer in a subject in need thereof by administering to the subject at least a first compound and a second compound together or separately. The first compound is an effective amount of a checkpoint inhibitor optionally with at least one pharmaceutically acceptable carrier. The second compound is an effective amount of an Anti-Tumor Immune Enhancer (ATIE) optionally with at least one pharmaceutically acceptable carrier. The compounds can be administered together or separately.
Source: PVGPATDIS, file of 2026-04-10 (ipg231114.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| AIM ImmunoTech Inc. 6 patents | US company or organization | Ocala, FL | AIM IMMUNOTECH INC. State business registration EXACT high confidence: identical full name and state AIM ImmunoTech Inc. Form D issuer EXACT high confidence: identical full name and state AIM IMMUNOTECH INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| David Strayer | Ocala, FL | 11 | PVGPATDIS, file of 2026-04-10 | |
| Thomas K. EQUELS | Ocala, FL | 5 | Person page FUZZY medium confidence | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/713 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P35/00 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K16/2827 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2020-01-08 | Assignment Assignment of assignor's interest | HEMISPHERX BIOPHARMA, INC. signed 2019-09-03 | AIM IMMUNOTECH INC. OCALA, FL | 51507/469 | ECORSEXC, file of 2026-09-25 |
| 2020-01-08 | Assignment Assignment of assignor's interest | EQUELS, THOMAS K. signed 2019-12-18 STRAYER, DAVID R. signed 2019-12-18 | HEMISPHERX BIOPHARMA, INC. OCALA, FL | 51449/938 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.